
基本信息:
- 专利标题: Small molecule toll-like receptor (TLR) antagonists
- 专利标题(中):小分子toll样受体(TLR)拮抗剂
- 申请号:US11543314 申请日:2006-10-04
- 公开(公告)号:US20070232622A1 公开(公告)日:2007-10-04
- 发明人: Grayson Lipford , Alexandra Forsbach , Charles Zepp
- 申请人: Grayson Lipford , Alexandra Forsbach , Charles Zepp
- 申请人地址: DE Langenfeld US MA Wellesley
- 专利权人: Coley Pharmaceutical GmbH,Coley Pharmaceutical Group, Inc.
- 当前专利权人: Coley Pharmaceutical GmbH,Coley Pharmaceutical Group, Inc.
- 当前专利权人地址: DE Langenfeld US MA Wellesley
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; A61P37/00 ; C07D239/70 ; C12N5/00
摘要:
The invention provides methods and compositions useful for modulating signaling through Toll-like receptors. The methods involve contacting a TLR-expressing cell with a small molecule having a core structure including at least two rings. Certain of the compounds are 4-primary amino quinolines. Many of the compounds and methods are useful specifically for inhibiting immune stimulation involving at least one of TLR9, TLR8, TLR7, and TLR3. The methods may have use in the treatment of autoimmunity, inflammation, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer, and immunodeficiency.
摘要(中):
本发明提供了用于通过Toll样受体调节信号传导的方法和组合物。 所述方法包括使TLR表达细胞与具有包含至少两个环的核心结构的小分子接触。 某些化合物是4-伯氨基喹啉。 许多化合物和方法专门用于抑制涉及TLR9,TLR8,TLR7和TLR3中的至少一种的免疫刺激。 该方法可用于治疗自身免疫,炎症,过敏,哮喘,移植物排斥,移植物抗宿主病,感染,败血症,癌症和免疫缺陷。
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/33 | .杂环化合物 |
----------A61K31/335 | ..仅有氧作为环杂原子的,例如制霉色基素 |
------------A61K31/40 | ...有仅以1个氮作为环杂原子的五元环的,例如舒必利、琥珀酰亚胺、托尔米丁、甲氧吡丁苯 |
--------------A61K31/50 | ....哒嗪;氢化哒嗪 |
----------------A61K31/519 | .....与杂环系统邻位或迫位稠合的 |